Name: In a 104-week trial involving patients with primary membranous nephropathy, the type II anti-CD20 antibody
Uploaded: 2026-09-14T11:20:01+00:00
Duration: 65 s
Channel: @nejm.org
Description: TikTok video by @nejm.org: 1,466 views, 56 likes, 2 comments, 4 shares, 11 saves. Engagement 4.23%.

tokgauge/ @nejm.org / video9 / 13Esc